Johnson & Johnson finalises acquisition of Japan beauty firm Ci:z Holdings

By Amanda Lim contact

- Last updated on GMT

Johnson & Johnson finalises acquisition of Japan beauty firm Ci:z Holdings
Johnson & Johnson has finalised the purchase of all of the outstanding shares of Japanese health and beauty firm Ci:z Holdings, which boasts brands such as Dr.Ci:Labo, Labo Labo and Genomer.

There were around 20 million shares of Ci:z not already held by Johnson & Johnson (J&J) tendered in the offer. This represents 41% of the outstanding share of the company.

J&J will acquire all tendered shares for ¥5,900 ($54.58) and purchase additional shares through the acquisition of CIC Corporation, the ownership vehicle of Ci:z founder, Yoshinori Shirono.

This will give J&J an aggregate ownership interest in Ci:z of 89%. J&J previously reported that the deal would be worth approximately ¥230 billion ($2.05 billion).

The finalisation of the deal is expected to take place on January 17.

After settlement and acquisition of CIC, J&J said it plans to buy out the remaining shares of Ci:z in the first half of 2019. It added that it plans to take action to delist the company from the Tokyo Stock Exchange.

Long-term partnership

In July 2016, Cilag GmbH International, an affiliate of J&J, entered into a long-term partnership with Ci:Z to help distribute its products outside Japan. As part of the deal, Cilag acquired approximately 19.9% of the company’s shares.

J&J announced plans to acquire the Japanese company in October to help strengthen its market presence in Japan and bolster its offering in science-based dermocosmetic brands.

"Health and beauty consumers are actively seeking science-based innovation to improve their skin,"​ said Jorge Mesquita, worldwide chairman, Johnson & Johnson Consumer.

"This transaction will maximise value creation for Johnson & Johnson's Consumer business by bringing in an agile innovation model and rapidly accelerating sales through our global commercialisation expertise."

Expanding footprint in Asia

The American multi-national made strides to increase its presence around Asia in 2018.

Aside from the acquisition of Ci:Z, J&J celebrated the grand opening of its regional headquarters in Singapore’s Science Park.

The new facility is home to the firm’s first design lab outside of New York, a Leadership Lab, and the company's first international Johnson & Johnson Human Performance Institute.

Related news

Show more

Related products

show more

New Data of ALPAFLOR® SCUTELLARIA AO

New Data of ALPAFLOR® SCUTELLARIA AO

DSM Nutritional Products, LLC | 18-Feb-2019 | Research Study

Global pollution – and its effects on the skin – will continue to be a key consumer concern in 2019. With urbanisation showing no signs of slowing, more...

Discover the news – Symrise @ PCHI booth 4F66

Discover the news – Symrise @ PCHI booth 4F66

Symrise | 11-Feb-2019 | Product Brochure

Go Green with 100% Bio-based carbon pentylene glycol, learn more about our sea ingredient that helps oily and sensitive skin, find out more about our modern...

Instant Ageless Skin for Complete Selfie Satisfaction

Instant Ageless Skin for Complete Selfie Satisfaction

TRI-K Industries Inc. | 21-Jan-2019 | Technical / White Paper

Fision® Instant Lift from TRI-K is a natural, Cosmos approved, non-GMO solution that provides immediate skin firming to minimize the appearance of wrinkles...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars